Next Article in Journal
cGMP-Dependent Protein Kinase Inhibitors in Health and Disease
Next Article in Special Issue
Interactions of a Dopamine D1 Receptor Agonist with Glutamate NMDA Receptor Antagonists on the Volitional Consumption of Ethanol by the mHEP Rat
Previous Article in Journal
RNAi Therapeutic Platforms for Lung Diseases
Review

NMDA Receptor Modulators in the Treatment of Drug Addiction

1
Department of Psychology, Arizona State University, Tempe, AZ 85287, USA
2
Interdisciplinary Graduate Program in Neuroscience, Arizona State University, Tempe, AZ 85287, USA
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2013, 6(2), 251-268; https://0-doi-org.brum.beds.ac.uk/10.3390/ph6020251
Received: 30 November 2012 / Revised: 29 January 2013 / Accepted: 29 January 2013 / Published: 6 February 2013
(This article belongs to the Special Issue NMDA Receptor Antagonists for Treatment of CNS Disorders)
Glutamate plays a pivotal role in drug addiction, and the N-methyl-D-aspartate (NMDA) glutamate receptor subtype serves as a molecular target for several drugs of abuse. In this review, we will provide an overview of NMDA receptor structure and function, followed by a review of the mechanism of action, clinical efficacy, and side effect profile of NMDA receptor ligands that are currently in use or being explored for the treatment of drug addiction. These ligands include the NMDA receptor modulators memantine and acamprosate, as well as the partial NMDA agonist D-cycloserine. Data collected to date suggest that direct NMDA receptor modulators have relatively limited efficacy in the treatment of drug addiction, and that partial agonism of NMDA receptors may have some efficacy with regards to extinction learning during cue exposure therapy. However, the lack of consistency in results to date clearly indicates that additional studies are needed, as are studies examining novel ligands with indirect mechanisms for altering NMDA receptor function. View Full-Text
Keywords: glutamate; N-methyl-D-aspartate receptor; glycine binding site; antagonist; partial agonist glutamate; N-methyl-D-aspartate receptor; glycine binding site; antagonist; partial agonist
Show Figures

Figure 1

MDPI and ACS Style

Tomek, S.E.; Lacrosse, A.L.; Nemirovsky, N.E.; Olive, M.F. NMDA Receptor Modulators in the Treatment of Drug Addiction. Pharmaceuticals 2013, 6, 251-268. https://0-doi-org.brum.beds.ac.uk/10.3390/ph6020251

AMA Style

Tomek SE, Lacrosse AL, Nemirovsky NE, Olive MF. NMDA Receptor Modulators in the Treatment of Drug Addiction. Pharmaceuticals. 2013; 6(2):251-268. https://0-doi-org.brum.beds.ac.uk/10.3390/ph6020251

Chicago/Turabian Style

Tomek, Seven E., Amber L. Lacrosse, Natali E. Nemirovsky, and M. F. Olive 2013. "NMDA Receptor Modulators in the Treatment of Drug Addiction" Pharmaceuticals 6, no. 2: 251-268. https://0-doi-org.brum.beds.ac.uk/10.3390/ph6020251

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop